Rob Thomsons Return to Philadelphia Adds Intrigue Ahead of Historic Phillies Game eHealth EHTH May See Increased Target as Operational Improvements Gain Traction KKR Co KKR Assessing the Alternative Asset Managers LongTerm Growth Potential Bitcoin Prices Slip on Thursday May 28 2026 Morning Losses Extend Decline SP 500 Edges Higher as Healthcare and Tech Lift Broadly Positive Session Corporate Confidence in Prediction Markets Grows Despite Regulatory Uncertainty Flowco Holdings Inc FLOC Q1 2026 Earnings Massive EPS Beat Overshadowed by Stock Decline HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue RNAC Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Teekay Tankers Q1 2026 Earnings EPS Surpasses Expectations Amid Strong Tanker Market DLR Q1 2026 Earnings EPS Beats Estimates Amid Data Center Demand CCL Q1 2026 Earnings Cruise Operator Beats EPS Expectations Despite Market Pullback CrowdStrike CRWD Surges 456 as Cybersecurity Demand Drives Momentum Cardlytics Inc CDLX Falls Nearly 5 as Stock Approaches Critical Support Level Linkage Global Inc LGCB Holds Steady Near Support as Traders Assess MicroCap Dynamics Molina Healthcare MOH Slides 43 as Sector Headwinds Weigh on Sentiment Faraday Future Warrant FFAIW Slides 893 as Stock Hovers Near Penny Territory DRCT Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Resilience LITS Q4 2024 Earnings Significant EPS Miss Raises Concerns Amid Lack of Revenue Disclosure Cadrenal Therapeutics Q1 2026 Earnings Narrowed Loss Surpasses Estimates Stock Edges Higher LSI Industries LYTS Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance Smart Share Global EM Q2 2024 Earnings Stellar EPS Beat Surges 42957 Above Estimates Nayax Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut Amid Product Expansion Plans Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Stable Underwriting Conditions Neumora Therapeutics NMRA Holds Steady at 185 as Stock Navigates Tight Range